» Articles » PMID: 19395656

The Colorectal Cancer Risk at 18q21 is Caused by a Novel Variant Altering SMAD7 Expression

Abstract

Recent genome-wide scans for colorectal cancer (CRC) have revealed the SMAD7 (mothers against decapentaplegic homolog 7) gene as a locus associated with a modest, but highly significant increase in CRC risk. To identify the causal basis of the association between 18q21 variation and CRC, we resequenced the 17-kb region of linkage disequilibrium and evaluated all variants in 2532 CRC cases and 2607 controls. A novel C to G single nucleotide polymorphism (SNP) at 44,703,563 bp was maximally associated with CRC risk (P = 5.98 x 10(-7); > or =1.5-fold more likely to be causal than other variants). Using transgenic assays in Xenopus laevis as a functional model, we demonstrate that the G risk allele leads to reduced reporter gene expression in the colorectum (P = 5.4 x 10(-3)). Electrophoretic mobility shift assays provided evidence for the role of Novel 1 in transcription factor binding. We propose that the novel SNP we have identified is the functional change leading to CRC predisposition through differential SMAD7 expression and, hence, aberrant TGF-beta signaling.

Citing Articles

Identification of potential functional variants and genes at 18q21.1 associated with the carcinogenesis of colorectal cancer.

Cheng X, Zhang F, Gong J, Li Y, Zhou D, Wang J PLoS Genet. 2022; 18(2):e1010050.

PMID: 35108261 PMC: 8870576. DOI: 10.1371/journal.pgen.1010050.


Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis.

Wu M, Yuan Y, Huang B, Chen J, Li B, Fang J Signal Transduct Target Ther. 2021; 6(1):395.

PMID: 34785655 PMC: 8595887. DOI: 10.1038/s41392-021-00781-3.


Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants.

Campbell P, Lin Y, Bien S, Figueiredo J, Harrison T, Guinter M J Natl Cancer Inst. 2020; 113(1):38-47.

PMID: 32324875 PMC: 7781451. DOI: 10.1093/jnci/djaa058.


The association between SMAD7 polymorphisms and colorectal cancer susceptibility as well as clinicopathological features in the Iranian population.

Akbari Z, Safari-Alighiarloo N, Aghdaei H, Vahedi M, Montazer Haghighi M, Matani Borkheili M Gastroenterol Hepatol Bed Bench. 2020; 13(1):23-30.

PMID: 32190221 PMC: 7069530.


Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Ortiz G, Li Y, Post S, Pant V, Xiong S, Larsson C Oncogene. 2017; 37(3):332-340.

PMID: 28925402 PMC: 5775049. DOI: 10.1038/onc.2017.344.


References
1.
Houlston R, Webb E, Broderick P, Pittman A, Di Bernardo M, Lubbe S . Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008; 40(12):1426-35. PMC: 2836775. DOI: 10.1038/ng.262. View

2.
Zanke B, Greenwood C, Rangrej J, Kustra R, Tenesa A, Farrington S . Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet. 2007; 39(8):989-94. DOI: 10.1038/ng2089. View

3.
Tuupanen S, Niittymaki I, Nousiainen K, Vanharanta S, Mecklin J, Nuorva K . Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res. 2008; 68(1):14-7. DOI: 10.1158/0008-5472.CAN-07-5766. View

4.
De Gobbi M, Viprakasit V, Hughes J, Fisher C, Buckle V, Ayyub H . A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science. 2006; 312(5777):1215-7. DOI: 10.1126/science.1126431. View

5.
Levy L, Hill C . Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2005; 17(1-2):41-58. DOI: 10.1016/j.cytogfr.2005.09.009. View